Back to Journals » Clinical Interventions in Aging » Volume 9

Long-term safety and tolerability of saxagliptin add-on therapy in older patients (aged ≥65 years) with type 2 diabetes

Total article views   HTML views PDF downloads Totals
9,746 Dovepress* 8,418+ 1,544 9,962
PubMed Central* 1,328 698 2,026
Totals 9,746 2,242 11,988
*Since 4 September 2014
+Since July 2016

View citations on PubMed Central and Google Scholar